Since acquiring Belfast-based Philips Digital and Computational Pathology business (formerly known as PathXL) in July this year, we have continued to refine and design PathXL Tutor, our digital pathology software platform for education and professional development.
Jonathan Armstrong is currently conducting extensive research into the use of Artificial Intelligence (AI) in medical imaging with particular focus on how it can enhance and speed up cancer diagnosis. Medical imaging is one of the greatest diagnostic aids available to physicians and they cover a plethora of different technologies..
We are delighted to announce that for the second consecutive year Cirdan has been awarded a place on the government’s latest, G-Cloud framework, the G-cloud 12. G-cloud is a UK government framework set up to encourage the adoption of cloud services across the public sector
“Having a very dedicated and experienced team around me helps make the overall task of instrument implementation a lot easier… This was displayed recently during lockdown with many of our clients requiring interfaces developed, tested and installed urgently.”
One of our innovations at the moment is Artificial Intelligence – or as we like to call it, Machine Learning. We are working on developing algorithms that can aid physicians and clinicians for
decision making in cancer diagnosis.
Eurofins Pathology has streamlined its histology processes and increased lab efficiency with the introduction of ULTRA Cloud, Cirdan’s cloud-based LIS hosted on the Microsoft Azure platform.
ULTRA is a dedicated Laboratory Information System (LIS), which has evolved over the years to meet the needs of high throughput, multi-site, public and private laboratories with complex and diverse requirements.
Medical informatics and imaging technology company, Cirdan has today announced that it has acquired the Belfast-based Philips Digital and Computational Pathology business (formerly known as PathXL).
Cirdan has three offices worldwide situated in two different hemispheres in three different time zones! This allows us to offer our customers 24/7 365 day support with a global follow-the-sun model.
We are excited to formally announce that we will be hosting a special Pathology Horizons webinar edition on Wednesday, 16th September 2020 at 15:00 (BST). This two-hour webinar will be in keeping with our usual Pathology Horizons theme i.e. the future of pathology but will focus particularly on the impact of COVID-19 for pathology and laboratory medicine.
Cirdan has successfully passed its recent surveillance audit for the Medical Device Single Audit Program (MDSAP), ISO 13485:2016 and ISO 9001:2015. Due to the ongoing pandemic this audit was held remotely with our Notified Body, BSI, which presented a new challenge for the team.
Cirdan is delighted to announce that it has signed an exclusive agreement with global healthcare firm, Becton, Dickinson and Company (BD) to distribute its CoreLite™ specimen radiography system in the United States and Canada.
Cirdan was delighted to be able to help Northern Pathology Victoria (NPV), the public pathology provider of Northern Health in Melbourne connect to the Australian Government’s My Health Record system.
CoreLite is a dedicated specimen x-ray system designed to verify microcalcifications of breast biopsy cores. It is compact and self contained and therefore can be located in the biopsy room where specimens are imaged and verified within seconds at the point of care.
It is with a heavy heart that we have decided to postpone this year’s Pathology Horizons conference as a result of the uncertainty around the COVID-19 pandemic and the international travel restrictions in place.
We are pleased to announce that the Pathology Horizons 2020 conference is going ahead as planned in Newcastle, Northern Ireland from 10-12 September.
As a result of the COVID-19 pandemic, laboratories across the world are being asked to rapidly scale up their testing capacity. In response to this we have been configuring our ULTRA Laboratory Information System (LIS) to facilitate this increased testing demand.
Cirdan has recently received a £1.5m funding boost from the Growth Finance Fund and plans to create 50 new jobs over the next three years. Cirdan has used the funding to facilitate its expansion plans with a move to larger offices and production facilities at the former Coca-Cola factory in Lambeg (Lisburn, N.Ireland).